Pharmacogenetics of the lipodystrophy syndrome associated with HIV infection and combination antiretroviral therapy

By Vidal Francesc   Domingo Pere   Viladés Consuelo   Peraire Joaquim   Arnedo Mireia   Alcamí José   Leal Manuel   Villarroya Francesc   Gatell Josep Ma  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 11, 2011-11 ,pp. : 1365-1382

Informa Healthcare

Access to resources Recommend Favorite

Lipodystrophy Syndrome in HIV Infection: What is it, What Causes it and How Can it Be Managed?

By Behrens G.M.N.   Stoll M.   Schmidt R.E.  

Drug Safety, Vol. 23, Iss. 1, 2000-07 ,pp. : 57-76

Adis International

Access to resources Recommend Favorite

Lipotoxicity on the Basis of Metabolic Syndrome and Lipodystrophy in HIV-1-Infected Patients Under Antiretroviral Treatment

By  

Current Pharmaceutical Design, Vol. 16, Iss. 30, 2010-10 ,pp. : 3372-3378

Bentham Science Publishers

Access to resources Recommend Favorite

The Metabolic Syndrome and HIV Infection

By  

Current Pharmaceutical Design, Vol. 20, Iss. 31, 2014-09 ,pp. : 4975-5003

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment Strategy Issues for Chronic HIV-1 Infection in Adults: The Dilemma of Life-long Antiretroviral Treatment

By  

Current Medicinal Chemistry - Anti-Infective Agents, Vol. 4, Iss. 1, 2005-01 ,pp. : 29-36

Bentham Science Publishers

Access to resources Recommend Favorite